Eric J Ende - Net Worth and Insider Trading
Eric J Ende Net Worth
The estimated net worth of Eric J Ende is at least $3 Million dollars as of 2024-04-30. Eric J Ende is the Director of Avadel Pharmaceuticals PLC and owns about 167,900 shares of Avadel Pharmaceuticals PLC (AVDL) stock worth over $3 Million. Eric J Ende is also the Director of Matinas BioPharma Holdings Inc and owns about 109,292 shares of Matinas BioPharma Holdings Inc (MTNB) stock worth over $20,055. Details can be seen in Eric J Ende's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Eric J Ende has not made any transactions after 2023-05-18 and currently still holds the listed stock(s).
Transaction Summary of Eric J Ende
Eric J Ende Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric J Ende owns 4 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , Matinas BioPharma Holdings Inc (MTNB) , and Progenics Pharmaceuticals Inc (PGNX) among others .
Click here to see the complete history of Eric J Ende’s form 4 insider trades.
Insider Ownership Summary of Eric J Ende
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2023-05-18 | director |
| MTNB | Matinas BioPharma Holdings Inc | 2019-08-20 | director |
| PGNX | Progenics Pharmaceuticals Inc | 2020-06-19 | director |
| NBSE | NeuBase Therapeutics Inc | 2022-01-01 | director |
Eric J Ende Latest Holdings Summary
Eric J Ende currently owns a total of 2 stocks. Among these stocks, Eric J Ende owns 167,900 shares of Avadel Pharmaceuticals PLC (AVDL) as of May 18, 2023, with a value of $3 Million and a weighting of 99.34%. Eric J Ende also owns 109,292 shares of Matinas BioPharma Holdings Inc (MTNB) as of August 20, 2019, with a value of $20,055 and a weighting of 0.66%.
Latest Holdings of Eric J Ende
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2023-05-18 | 167,900 | 17.97 | 3,017,163 |
| MTNB | Matinas BioPharma Holdings Inc | 2019-08-20 | 109,292 | 0.18 | 20,055 |
Holding Weightings of Eric J Ende
Eric J Ende Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric J Ende has made a total of 9 transactions in Avadel Pharmaceuticals PLC (AVDL) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Avadel Pharmaceuticals PLC is the acquisition of 13,000 shares on May 18, 2023, which cost Eric J Ende around $181,090.
According to the SEC Form 4 filings, Eric J Ende has made a total of 2 transactions in Matinas BioPharma Holdings Inc (MTNB) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Matinas BioPharma Holdings Inc is the acquisition of 20,000 shares on August 20, 2019, which cost Eric J Ende around $13,200.
Insider Trading History of Eric J Ende
- 1
Eric J Ende Trading Performance
GuruFocus tracks the stock performance after each of Eric J Ende's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric J Ende is 57.08%. GuruFocus also compares Eric J Ende's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric J Ende within 3 months outperforms 8 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric J Ende's insider trading performs compared to the benchmark.
Performance of Eric J Ende
Average Return
111.63%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.29 | 57.08 | 86.94 | 111.63 | 6.69 | 16.63 |
| Relative Return to S&P 500(%) | -2.36 | 53.2 | 79.33 | 93.63 | -10.77 | 6.09 |
Eric J Ende Ownership Network
Ownership Network List of Eric J Ende
Ownership Network Relation of Eric J Ende
Eric J Ende Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Eric J Ende is the director of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Eric J Ende made 2 insider transaction in Avadel Pharmaceuticals PLC (AVDL) with a net purchase of 33,000. Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net purchase of 9,000 shares made by Thomas S Mchugh , a net sale of 103,975 shares made by Mark Anthony Mccamish , and a net purchase of 4,500 shares made by Linda Palczuk .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 70,500 shares were bought by its insiders, resulting in a net sale of 33,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Eric J Ende Mailing Address
Above is the net worth, insider trading, and ownership report for Eric J Ende. You might contact Eric J Ende via mailing address: C/o Matinas Biopharma Holdings, Inc., 1545 Route 206 South, Suite 302, Bedminster Nj 07921.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
